Literature DB >> 15258577

P2X7 receptor inhibition improves recovery after spinal cord injury.

Xiaohai Wang1, Gregory Arcuino, Takahiro Takano, Jane Lin, Wei Guo Peng, Pinglan Wan, Pingjia Li, Qiwu Xu, Qing Song Liu, Steven A Goldman, Maiken Nedergaard.   

Abstract

Secondary injury exacerbates the extent of spinal cord insults, yet the mechanistic basis of this phenomenon has largely been unexplored. Here we report that broad regions of the peritraumatic zone are characterized by a sustained process of pathologic, high ATP release. Spinal cord neurons expressed P2X7 purine receptors (P2X7R), and exposure to ATP led to high-frequency spiking, irreversible increases in cytosolic calcium and cell death. To assess the potential effect of P2X7R blockade in ameliorating acute spinal cord injury (SCI), we delivered P2X7R antagonists OxATP or PPADS to rats after acute impact injury. We found that both OxATP and PPADS significantly improved functional recovery and diminished cell death in the peritraumatic zone. These observations demonstrate that SCI is associated with prolonged purinergic receptor activation, which results in excitotoxicity-based neuronal degeneration. P2X7R antagonists inhibit this process, reducing both the histological extent and functional sequelae of acute SCI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258577     DOI: 10.1038/nm1082

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  180 in total

1.  Inhibition of the P2X7 receptor reduces cystogenesis in PKD.

Authors:  Ming-Yang Chang; Jenn-Kan Lu; Ya-Chung Tian; Yung-Chang Chen; Cheng-Chieh Hung; Yi-Hui Huang; Yau-Hung Chen; Mai-Szu Wu; Chih-Wei Yang; Yi-Chuan Cheng
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

2.  Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats.

Authors:  Dong Zhou; Meng-Ling Chen; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

3.  A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.

Authors:  Alexander Marcillo; Beata Frydel; Helen M Bramlett; W Dalton Dietrich
Journal:  Exp Neurol       Date:  2011-11-10       Impact factor: 5.330

Review 4.  Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.

Authors:  Davide Lecca; Stefania Ceruti; Marta Fumagalli; Maria P Abbracchio
Journal:  Purinergic Signal       Date:  2012-04-12       Impact factor: 3.765

5.  P2X4 receptors influence inflammasome activation after spinal cord injury.

Authors:  Juan Pablo de Rivero Vaccari; Dominic Bastien; Geoffrey Yurcisin; Isabelle Pineau; W Dalton Dietrich; Yves De Koninck; Robert W Keane; Steve Lacroix
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

6.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

7.  Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in photoreceptor cell death.

Authors:  Shoji Notomi; Toshio Hisatomi; Takaaki Kanemaru; Atsunobu Takeda; Yasuhiro Ikeda; Hiroshi Enaida; Guido Kroemer; Tatsuro Ishibashi
Journal:  Am J Pathol       Date:  2011-10-08       Impact factor: 4.307

Review 8.  Purinergic signaling: a novel mechanism in immune surveillance.

Authors:  Lin Mei; Wei Du; Wei Gao; Qi-bing Mei
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

Review 9.  AMPA-receptor trafficking and injury-induced cell death.

Authors:  Michael S Beattie; Adam R Ferguson; Jacqueline C Bresnahan
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

10.  P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control.

Authors:  Tobias Engel; Alba Jimenez-Pacheco; Maria Teresa Miras-Portugal; Miguel Diaz-Hernandez; David C Henshall
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.